Short term effect of SGLT2 inhibitor, Dapagliflozin added on to standard therapy in decompensated heart failure patients with diabetes mellitus
29 August 2017 (10:05 - 10:55)
Organised by:
Abstract
Slides
About the speaker
University of Toyama, Toyama (Japan)
6 More presentations in this session
Doctor K. Ozieranski (Warsaw, PL)
Associate Professor J. Siller-Matula (Vienna, AT)
Ms L. Qin (Gaithersburg, US)
Doctor P. Jorgensen (Hellerup, DK)
Doctor D. Fitchett (Toronto, CA)
Access the full session
The Event
ESC Congress 2017
29 August 2017
10:05 CET
You may be interested in
Congress Presentation
Congress Session
20 May 2025
Congress Session
17 May 2025
Congress Presentation
